American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $68 | $52 | $13 | $42 |
| - Cash | $63 | $19 | $34 | $75 |
| + Debt | $147 | $144 | $151 | $129 |
| Enterprise Value | $153 | $176 | $130 | $96 |
| Revenue | $491 | $470 | $434 | $364 |
| % Growth | 4.4% | 8.4% | 19.1% | – |
| Gross Profit | $43 | $37 | $29 | $9 |
| % Margin | 8.7% | 7.8% | 6.8% | 2.6% |
| EBITDA | $9 | $5 | $3 | -$16 |
| % Margin | 1.9% | 1.1% | 0.7% | -4.3% |
| Net Income | $1 | -$1 | $4 | -$8 |
| % Margin | 0.3% | -0.2% | 0.8% | -2.2% |
| EPS Diluted | -0.003 | -0.19 | 0.038 | -1.22 |
| % Growth | 98.7% | -606.7% | 103.1% | – |
| Operating Cash Flow | $12 | -$28 | $45 | $45 |
| Capital Expenditures | -$6 | -$6 | -$4 | -$4 |
| Free Cash Flow | $6 | -$35 | $41 | $41 |